Application no. and date | 05728092.7 (espacenet) (Federated) (European Patent Register), 20050311 | Patent/reg. no. and date | DK/EP 1725548, 20150114 | Publication date | 20061129 | Priority no. and date | US 552480 P, 20040312 | EP pub. no. and date |
EP 1725548 20061129 | Effective date | | Applicant/owner | Vertex Pharmaceuticals Incorporated, 50 Northern Avenue
Boston, MA 02210, US | Applicant ref. no. | P81500896DK00E | Inventor | TANOURY, Gerald, J., 1 Orchard Drive
Hudson, MA 01749, US, SNOONIAN, John, R., 1 Blueberry Circle
Ayer, MA 01432, US, TRUDEAU, Martin, 24 Randolph Drive
Tewksbury, MA 01876, US, NYCE, Philip, L., 18 Prospect Street
Milbury, MA 01527, US, GUERIN, David, J., 16 Huntington Street
Natick, MA 01760, US, JONES, Andrew, D., 1289 Great Plain Avenue
Needham, MA 02492, US, CHEN, Minzhang, 35 Squirrel Hill Road
Acton, MA 01720, US | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Opponent | | IPC Class | C07D 405/12 (2006.01) | Title | Fremgangsmåde og mellemprodukter til fremstilling af asparaginacetal-caspase-inhibitorer | Int. application no. | US2005008251 | Int. publication no. | WO2005090334 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|